1. Home
  2. KITT vs REVB Comparison

KITT vs REVB Comparison

Compare KITT & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nauticus Robotics Inc.

KITT

Nauticus Robotics Inc.

N/A

Current Price

$1.37

Market Cap

2.4M

Sector

Industrials

ML Signal

N/A

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

N/A

Current Price

$4.00

Market Cap

1.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KITT
REVB
Founded
2014
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
1.9M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
KITT
REVB
Price
$1.37
$4.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $124.25
AVG Volume (30 Days)
★ 77.2K
71.2K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
71.55
★ 72.68
EPS
N/A
★ N/A
Revenue
★ $11,434,959.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 33.10
N/A
52 Week Low
$0.39
$0.44
52 Week High
$3.50
$4.06

Technical Indicators

Market Signals
Indicator
KITT
REVB
Relative Strength Index (RSI) 54.27 81.28
Support Level $1.22 $0.89
Resistance Level $1.41 $4.06
Average True Range (ATR) 0.11 0.27
MACD -0.01 0.19
Stochastic Oscillator 52.78 96.40

Price Performance

Historical Comparison
KITT
REVB

About KITT Nauticus Robotics Inc.

Nauticus Robotics Inc is a technology-driven company specializing in the development of fully electric autonomous robotic solutions for subsea applications. Its portfolio includes autonomous underwater vehicles (AUVs), electric robotic manipulators, a platform-agnostic robotic operating system, and related engineering, consulting and prototype services. The Company's solutions enable autonomous operations for both commercial and defense sectors, with alignment to offshore energy and national security interests. Its addressable markets include upstream, midstream and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research and subsea mining, with current focus on oil and gas operations and defense applications.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

Share on Social Networks: